Search clinical trials for: Cardiovascular Events

Total 62563 results

Amgen

Completed

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Coronary Artery Disease (CAD)

Australia, Czechia, Italy, United States, Netherlands, Hungary, Germany
Bayer
Janssen, LP

Completed

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid (XATOA)

Atherosclerosis

Germany, Argentina, Brazil, Canada, Denmark, Israel, Korea, Republic of, Lebanon, Luxembourg, Mexico, Norway, Russian Federation, Slovenia, Sweden, Switzerland, Thailand, United Arab Emirates, United Kingdom
Andres muñoz
Hospital Clinic of Barcelona; LEO Pharma; Hospital General Universitario Elche; Hospital Universitario Ramon y Cajal and other collaborators

Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (ONCOTHROMB)

Genetic Predisposition | Cancer-associated Thrombosis

Spain
Amarin Pharma Inc.

Completed

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin (REDUCE-IT)

Cardiovascular Diseases

United States, Australia, Canada, India, Netherlands, New Zealand, Poland, Romania, Russian Federation, South Africa, Ukraine
AstraZeneca

Completed

Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice (ALETHEIA)

Myocardial Infarction (MI)

Sweden, United Kingdom, United States, Italy, Germany
Lviv National Medical University

Completed

Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants (DBBA)

Postoperative Pain | Anesthesia, Local | Anesthesia | Peripheral Neuropathy | Pain Syndrome | Intraoperative Hypotension | Local Anesthetic Systemic Toxicity | Intraoperative Hypertension | Fractures of the Upper Limb | Fracture of the Lower Limb (Except Hip), Initial Encounter

Ukraine
Qian geng

Completed

Predictive Value of Cardiovascular Magnetic Resonance Related Parameters in STEMI Patients After Primary PCI for Adverse Left Ventricular Remodeling and Major Adverse Cardiovascular Events

Cardiovascular Diseases

China
China Academy of Chinese Medical Sciences

Completed

Risk Assessment Model for Ischemic Stroke Endpoint Events

Ischemic Stroke

China
Nanjing First Hospital, Nanjing Medical University

Completed

Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease (PREDICTION-NJ)

Coronary Artery Disease

China
Clinique Bizet

Completed

Evaluation and Comparison of Two Biomarkers (VOP and SCC) for the Prognosis of the Occurrence of Clinical Cardiovascular Events (VOP-SCC)

Cardiovascular Risk Factor

France
Centre de Recherche de l'Institut Universitaire...
Hospital Clinic of Barcelona; Montreal Heart Institute; St. Boniface Hospital; Toronto... and other collaborators

Completed

Patent Foramen Ovale Closure in Older Patients (PFO-Elderly)

Ischemic Stroke | Older People | Patent Foramen Ovale

Canada
University Hospital, Bordeaux

Completed

Correlation Between Clonal Hematopoiesis, Cardio-vascular Events, Inflammation and Atherosclerosis (CHATH)

Myocardial Infarction

France
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...

Active, not recruiting

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D)

Type2 Diabetes | Renal Disease | Cardiovascular Events

United States
University Hospital, Bordeaux

Completed

Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) (TICTAVI)

Aortic Valve Stenosis

France
Seoul National University Hospital

Active, not recruiting

Association Between Lipid Profiles and Cardiovascular Events (KORLIPID)

Cardiovascular Diseases | Dyslipidemias

Korea, Republic of
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; National Heart, Lung, and Blood... and other collaborators

Completed

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure (INVESTED)

Myocardial Infarction | Heart Failure

United States, Canada, Puerto Rico
Pfizer

Completed

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Atrial Fibrillation

Colombia
Centre Hospitalier Universitaire de Saint Etienne

Terminated

Stress Test on the Prediction of Cardiovascular Events in a High-risk Firefighter Population (FIRE-PREV)

Firefighter | High Cardiovascular Risk

France
Changhai Hospital
Putuo Hospital, Shanghai University of Traditional Chinese Medicine; No. 904... and other collaborators

Active, not recruiting

Association Between Carotid Plaque Length and Cardiovascular Events

Coronary Arteriosclerosis

China
Bayer

Completed

Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")

Prevention of Thromboembolic Events

Germany
Centro Hospitalar Tondela-Viseu
Portuguese IBD Group

Completed

Inflammatory Bowel Disease and Thromboembolic Events

Inflammatory Bowel Diseases | Coagulation Disorder | Thromboembolism

Portugal
University of Monastir

Completed

Prognostic Value of Non-invasive Index of Endothelial Function.

Chest Pain | Major Adverse Cardiovascular Events

Tunisia
Assistance Publique - Hôpitaux de Paris
Pr Nathalie COSTEDOAT-CHALUMEAU

Completed

Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus (HEMATOPLUS)

Systemic Lupus Erythematosus

France
Beijing Tiantan Hospital
Ministry of Science and Technology of the People´s Republic of China

Completed

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II (CHANCE-2)

Stroke | Transient Ischemic Attack

China
Penumbra Inc.

Completed

Imaging Guided Patient Selection for Interventional Revascularization Therapy (START)

Acute Ischemic Stroke

United States
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Pulmonary Embolism | Cerebral Stroke | Thrombosis, Deep Vein
University of British Columbia
Providence Health & Services; Vancouver Coastal Health

Withdrawn

Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study (COPMAN)

Myocardial Infarction | Myocardial Injury | Major Adverse Cardiac Events | Infectious Complications

Canada
University Hospital, Montpellier

Completed

One Year Follow-up After Rescuscited Cardiac Arrest (ONYRCA)

Cardiac Arrest

France
University of Thessaly

Completed

MACE and PE in Elective Primary TKA & THA

Stroke | Death | Transient Ischemic Attack | Pulmonary Embolism | Cardiovascular Complication

Greece
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Pulmonary Embolism | Thrombosis, Deep Vein
Hospital Clínico Universitario de Valladolid

Active, not recruiting

Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI) (RASTAVI)

Angiotensin-Converting Enzyme Inhibitors | Transcatheter Aortic Valve Replacemen

Spain
Guangdong Provincial People's Hospital
First Affiliated Hospital of Fujian Medical University; Shenzhen People's Hospital and other collaborators

Completed

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

Coronary Artery Disease | Kidney Diseases | Metabolic Syndrome | Cardio-Renal Syndrome | Coronary Angiography

China
Radboud University Medical Center

Active, not recruiting

Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions (PECTUS-obs)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome

Netherlands
Guangdong Provincial People's Hospital

Completed

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention

Coronary Artery Disease | Kidney Diseases | Metabolic Syndrome | Cardio-Renal Syndrome | Coronary Angiography

China
Intermountain Health Care, Inc.
Boehringer Ingelheim

Completed

Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation (CAF)

Dementia | Cognition Disorders | Cerebral Ischemic Events

United States
Resverlogix Corp
PPD; ICON plc; Medidata Solutions

Completed

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD (BETonMACE)

Coronary Artery Disease | Diabetes Mellitus, Type 2

Netherlands, Taiwan, Argentina, Israel, Poland, Russian Federation, Australia, Belgium, Serbia, Bulgaria, Hungary, Slovakia, Mexico, Croatia, Germany
Les Laboratoires des Médicaments Stériles

Completed

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Gastrointestinal Neoplasms | Thromboembolic Event

Tunisia
Quark Pharmaceuticals

Terminated

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Cardiac Surgery

United States, Germany, Spain, Australia, Austria, Canada, New Zealand, United Kingdom, Belgium, Czechia, France
AstraZeneca

Completed

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease (Dapa-CKD)

Chronic Kidney Disease

United States, Canada, Spain, United Kingdom, Denmark, Germany, Korea, Republic of, Brazil, Hungary, Mexico, Peru, Philippines, Vietnam, China, Japan, Argentina, Ukraine, Poland, Russian Federation, India, Sweden
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Domperidone and Risk of Serious Cardiac Events in Postpartum Women

Breast Feeding | Sudden Cardiac Death | Lactation | Ventricular Tachyarrhythmia

Canada
Biobeat Technologies Ltd.

Completed

Monitoring Patients With Acute Cardiac Disease Using a Wireless, Wearable, Non-invasive Monitor

Acute Cardiac Event | Acute Cardiac Failure | Acute Cardiac Pulmonary Edema

Israel
Alejandro Rodriguez Oviedo , MD

Terminated

Myocardial Injury and Severe Pneumococcal Pneumonia (NEUMOCAR)

Myocardial Ischemia | Pneumonia, Pneumococcal

Spain
Samsung Medical Center
Boston Scientific Corporation

Active, not recruiting

DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES) (DEDiCATES)

Sleep Disorder | Cardiac Event | Cardiac Arrythmias | Cardiac Implantable Electronic Device

Korea, Republic of
University Hospital, Bordeaux

Completed

Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19 (RYTHMO-COV)

Arrhythmia | SARS-CoV-2 Infection

France
Hospices Civils de Lyon

Completed

Pilot Study of ILIADE : Exploring Health Literacy Within Patients Hospitalized for Acute Cardiovascular Events (P-ILIADE)

Chronic Heart Failure | Acute Myocardial Infarction

France
Ziv Hospital

Completed

Is Hemodialysis Associated With Cardiac Markers Change?

Renal Insufficiency, Chronic

Israel
Hospital Universitario Reina Sofia de Cordoba

Completed

CORonary Diet Intervention With Olive Oil and Cardiovascular PREVention (CORDIOPREV)

Myocardial Infarction | Diabetes Mellitus | Metabolic Syndrome | Cognitive Decline | Unstable Angina | Malignancy

Spain
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study (TRIDENT-MRI)

Stroke | Hypertension | Cerebral Small Vessel Diseases | Vascular Dementia | Intracerebral Hemorrhage

Australia
Abbott Medical Devices

Completed

Lead Registry for Optim Leads (OPTIMUM)

Optim Lead Insulation Related Adverse Events

United States, Belgium, Germany

Search clinical trials for: Cardiovascular Events

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations